Polymer conjugates of the highly potent cytostatic drug 2-pyrrolinodoxorubicin

European Journal of Pharmaceutical Sciences

Volumn 42, Issue 1-2, 2011, Pages 156-163

  Studenovsky, M ^a   Ulbrich, K ^a   Ibrahimova, M ^b   Rihova, B ^b  

^a INSTITUTE OF MACROMOLECULAR CHEMISTRY   (Czech Republic)

^b INSTITUTE OF MICROBIOLOGY   (Czech Republic)

Author keywords

Anticancer agents; Multidrug resistance; PH controlled release; Polymer conjugates; Tumor drug delivery

Indexed keywords

2 PYRROLINODOXORUBICIN; 4 IODOBUTYRALDEHYDE; ALDEHYDE DERIVATIVE; DRUG CARRIER; HYDRAZONE DERIVATIVE; N (2 HYDROXYPROPYL)METHACRYLAMIDE COPOLYMER; UNCLASSIFIED DRUG;

ARTICLE; BIOCOMPATIBILITY; CANCER CELL CULTURE; CANCER INHIBITION; CHEMICAL BOND; CONTROLLED STUDY; CYTOSTASIS; CYTOTOXICITY; DRUG CONJUGATION; DRUG HYDROLYSIS; DRUG RELEASE; DRUG STABILITY; FEMALE; HUMAN; HUMAN CELL; IN VITRO STUDY; LYMPHOMA; MOUSE; NONHUMAN; PH; POLYMERIZATION; PRIORITY JOURNAL; T CELL LYMPHOMA; T LYMPHOCYTE; TUMOR GROWTH;

ANIMALS; ANTIBIOTICS, ANTINEOPLASTIC; CELL LINE, TUMOR; CELL PROLIFERATION; DOSE-RESPONSE RELATIONSHIP, DRUG; DOXORUBICIN; DRUG CARRIERS; FEMALE; HUMANS; LYMPHOMA, T-CELL; MICE; MOLECULAR STRUCTURE; POLYMETHACRYLIC ACIDS; PYRROLES; SOLUBILITY; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 78650677484     PISSN: 09280987     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejps.2010.11.006     Document Type: Article

References (17)

1. J. Bedrnicek, A. Vicha, M. Jarosova, M. Holzerova, J. Cinatl Jr., M. Michaelis, J. Cinatl, and T. Eckschlager Characterization of drug-resistant neuroblastoma cell lines by comparative genomic hybridization Neoplasma 52 2005 415 419
2. M. Binaschi, M. Bigioni, A. Cipollone, C. Rossi, C. Goso, C.A. Maggi, G. Capranico, and F. Animati Anthracyclines: selected new developments Curr. Med. Chem. - Anti-Cancer Agents 1 2001 113 130
3. R. Duncan Development of HPMA copolymer-anticancer conjugates: clinical experience and lessons learnt Adv. Drug Delivery Rev. 61 2009 1131 1148
4. R. Duncan, P. Kopeckova-Rejmanova, and J. Strohalm Anticancer agents coupled to N-(2-hydroxypropyl)methacrylamide copolymers. I. Evaluation of daunomycin and puromycin conjugates in vitro Br. J. Cancer 55 1987 165 174
5. T. Etrych, M. Jelinkova, B. Rihova, and K. Ulbrich New HPMA copolymers containing doxorubicin bound via pH-sensitive linkage synthesis and preliminary in vitro and in vivo biological properties J. Control. Release 73 2001 89 102
6. T. Etrych, T. Mrkvan, P. Chytil, C. Konak, B. Rihova, and K. Ulbrich N-(2-hydroxypropyl)methacrylamide-based polymer conjugates with pH-controlled activation of doxorubicin. I. New synthesis, physicochemical characterization and preliminary biological evaluation J. Appl. Polym. Sci. 109 2008 3050 3061
7. M. Hruby, J. Kucka, O. Lebeda, H. Mackova, M. Babic, C. Konak, M. Studenovsky, A. Sikora, J. Kozempel, and K. Ulbrich New bioerodable thermoresponsive polymers for possible radiotherapeutic applications J. Control. Release 119 2007 25 33
8. J. Kopecek, and R. Duncan Targetable polymeric prodrugs J. Control. Release 6 1987 315 327
9. H. Maeda, J. Wu, T. Sawa, Y. Matsumura, and K. Hori Tumor vascular permeability and the EPR effect in macromolecular therapeutics: a review J. Control. Release 65 2000 271 284
10. Y. Matsumura, and H. Maeda A new concept for macromolecular therapeutics in cancer chemotherapy: mechanism of tumoritropic accumulation of proteins and the antitumor agent smancs Cancer Res. 46 1986 6387 6392
11. A. Nagy, P. Armatis, and A.V. Schally High yield conversion of doxorubicin to 2-pyrrolinodoxorubicin, an analog 500-1000 times more potent: structure-activity relationship of daunosamine-modified derivatives of doxorubicin Proc. Natl. Acad. Sci. U.S.A. 93 1996 2464 2469
12. O. Pillai, and R. Panchagnula Polymers in drug delivery Curr. Opin. Chem. Biol. 5 2001 447 451
13. B. Rihova Antibody-targeted HPMA copolymer-bound anthracycline antibiotics Drugs Future 28 2003 1189 1210
14. B. Rihova, and J. Kopecek Biological properties of targetable poly[N-(2-hydroxypropyl)-methacrylamide]-antibody conjugates J. Control. Release 2 1985 289 310
15. L.W. Seymour, Y. Miyamoto, H. Maeda, M. Brereton, J. Strohalm, K. Ulbrich, and R. Duncan Influence of molecular weight on passive tumour accumulation of a soluble macromolecular drug carrier Eur. J. Cancer 31 1995 766 770
16. M.B. Smith, and J. March Advanced Organic Chemistry 5th ed. 2001 Wiley Interscience New York pp. 1218-1223
17. K. Ulbrich, V. Subr, J. Strohalm, D. Plocova, M. Jelinkova, and B. Rihova Polymeric drugs based on conjugates of synthetic and natural macromolecules. I. Synthesis and physico-chemical characterization J. Control. Release 64 2000 63 79